Management Forum Logo

Presented by
Management Forum

Upstream and Downstream Manufacturing in the Biopharmaceutical Industry Training Course

In this talk, explore the fundamental concepts, techniques, and processes that make up the backbone of biomanufacturing, pharmaceutical production, and biotechnology.

11 June 2026
+ 18 November 2026 »

from £99

Need help?  Enrol/reserve

Part of Molecule to Medicine series:

Are you seeking an understanding of the steps that turn scientific innovations into therapeutic products? This exciting series provides a concise overview of the drug development process, from early-stage research through to the creation of medicines. Participants will learn about key topics such as molecule discovery, preclinical testing, clinical trials, and the regulatory processes involved in bringing a medicine to market.

Overview

Bioprocessing is the use of biological systems (such as cells, enzymes, or microorganisms) to produce valuable products, like pharmaceuticals, biofuels, or specialty chemicals. This process is typically broken down into two main stages: upstream processing and downstream processing. Both play vital roles in ensuring the efficient production, purification, and quality control of the final product.

Upstream processing encompasses everything that occurs before the actual production of the product, and it’s primarily concerned with creating an optimal environment for microorganisms or cell cultures to grow and produce the target product.

Once the biological system has generated the product in upstream processing, the focus shifts to downstream processing, which involves purification and formulation to ensure the product is safe, pure, and suitable for commercial use.

Upstream and downstream processes are interconnected. The choice of cell culture methods, fermentation conditions, and media formulation can significantly affect the yield and purity of the product, which in turn impacts the complexity and cost of downstream processing.

This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.

Benefits of attending

Attending this session will not only deepen your knowledge but also equip you with the practical tools and strategies needed to enhance both upstream and downstream manufacturing processes, improve product quality, and navigate the complexities of the biopharmaceutical industry. The benefits of attending this session include:

  • Learn about the latest industry trends, technologies, and strategies being employed to improve upstream and downstream processes. This can help you adopt cutting-edge practices to enhance operational efficiency and reduce production costs
  • Understand key challenges and innovative solutions related to process optimisation, scale-up, and product consistency across both upstream and downstream stages. Knowledge in this area can help reduce bottlenecks and improve yield
  • See best practices in maintaining product quality, with a focus on techniques like process validation, quality assurance, and regulatory compliance to ensure the safety and effectiveness of biologics
  • Engage with experts, researchers, and other professionals in the biopharmaceutical field
  • Gain insights into the regulatory requirements for both upstream and downstream biopharmaceutical manufacturing processes. This can help ensure compliance with FDA, EMA, and other regulatory bodies, minimising the risk of delays or regulatory hurdles
  • Explore the latest technological advancements in biomanufacturing, such as automation, artificial intelligence, and continuous manufacturing processes, and how these can be integrated into both upstream and downstream operations to improve efficiency and scalability
  • Discuss the factors that contribute to cost reduction in the production process, such as the selection of cost-effective raw materials, automation, and process optimisation techniques. This knowledge can help drive profitability without compromising product quality
  • Delve into upstream and downstream processes and see how they fit into the larger context of the product life cycle, from discovery through clinical trials to commercial production

 

Who should attend?

  • Bioprocess engineers
  • Process development scientists
  • Quality Assurance (QA) and Quality Control (QC) professionals
  • Manufacturing supervisors and operators
  • Regulatory affairs managers
  • R&D (Research and Development) team members
  • Project managers in biotechnology/pharmaceuticals
  • Supply chain and logistics teams
  • Senior leadership (e.g., CTOs, VPs of Operations)
  • External consultants and contractors
  • Finance and costing analysts
  • Students and trainees in biotechnology and pharmaceutical sciences
  • Environmental Health and Safety (EHS) personnel
  • Automation and IT specialists

Enrol/reserve

Mustafa Edik

Mustafa Edik is a leading pharmaceutical, biotechnoloy, medical device quality and GXP expert with over 28 years of hands-on leadership in GMP, GDP, GCP, GLP, and broader GxP compliance across the pharmaceutical, biotechnology, and medical device industries.

As Turkey's first IRCA-certificated Lead Auditor for GMP and Pharmaceutical Quality Management Systems (PQMS), he brings unmatched credibility and depth to audits, compliance strategies, and regulatory readiness. Holding a BSc in Chemistry, and a BSc (Hons) in Biopharmaceutical Sciences & Engineering from Atlantic Technological University (Ireland), and an Executive MBA, Mustafa combines strong scientific foundations with strategic business acumen.

His career highlights include senior roles at Bayer Türkiye, where he progressed from Quality Control Lab Supervisor to Deputy QA Manager, and GMP Lead Auditor to Global GMP Lead Auditor, managing complex quality operations and audits in a multinational environment. He has personally led more than 4,200 hours of GxP audits across over 200 facilities worldwide.

Today, as Founder and Lead Consultant at Quality Academia Eğitim & Danışmanlık, Mustafa delivers high-impact consulting, training, and project management services to local and global clients. His expertise spans across:

  • GMP/GDP audits and supplier qualification
  • Validation, qualification, and quality risk management (ICH Q9)
  • Root cause analysis, CAPA, OOS/OOT, change control, and data integrity
  • Sterile/non-sterile manufacturing, process improvement, and cost-of-quality optimisation
  • Clinical trials (GCP & ICH E6), pharmacovigilance, and third-party manufacturing
  • Regulatory alignment with FDA, EMA, PIC/S, MHRA, TGA, TMMDA, WHO, and ICH standards

Mustafa has trained over 9,000 professionals in GxP topics and designed certified auditor programs for Turkish authorities including Turkish MOH and Ministry of Agriculture and Foresty. He served as Principal GMP Consultant & Auditor at the Turkish Atomic Energy Authority, supporting successful TMMDA GMP approvals for 5 radiopharmaceutical products. As the first Turkish consultant selected by the Developing Countries Vaccine Manufacturers Network (DCVMN), he has led teams of 100+ engineers, auditors, and quality specialists while managing dozens of international projects.

A prolific author, Mustafa's works include:

  • “Sorularla GMP Dokümantasyonu” – a practical guide to GMP documentation
  • “GMP Audits in Pharmaceutical and Biotechnology Industries” (Taylor & Francis / CRC Press, June 2024) – a comprehensive reference on effective GMP auditing practices

Recognised internationally for his practical, risk-based approach and knowledge transfer focus, Mustafa Edik is dedicated to elevating pharmaceutical quality standards, helping companies achieve compliance excellence, reduce risks, and drive operational efficiency.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

11 June 2026

Live online

12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15973

  • GBP 99 124
  • EUR 139 174
  • USD 160 199

Until 07 May

View basket 

 
Not ready to book yet?

for 7 days, no obligation

18 November 2026

Live online

12:00-13:30 UK (London) (UTC+00)
13:00-14:30 Paris (UTC+01)
07:00-08:30 New York (UTC-05)
Course code 16312

  • GBP 99 124
  • EUR 139 174
  • USD 160 199

Until 14 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Switzerland

  • Roche

Enrol/reserve

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to our team to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Harry Altamont

Harry
ALTAMONT

Aleksandra Beer

Aleksandra
BEER

+44 (0)20 7749 4749

inhouse@ipiacademy.com